Kowa of Japan To Sell OTC Drugs Directly To Drugstores
This article was originally published in PharmAsia News
Kowa, a Japanese drug maker, plans to drop wholesalers and market all of its over-the-counter drugs directly to drugstores beginning in April. The firm markets about 110 drugs to 40,000 drugstores and pharmacies in Japan through wholesalers. About 30 of the drugs are made by a subsidiary it bought in 2005. Still, the company figures that only three percent of its sales will be from OTC drugs. Kowa plans to double the number of its sales representatives to about 360 to accommodate the change. (Click here for more - may require a subscription
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.